Company profile for BrainXell

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

BrainXell, founded in 2015 by stem cell neuroscience pioneer Dr. Su Chun Zhang, develops high purity human neurons from iPSCs to support drug discovery and neurological research. Using proprietary directed differentiation technology, we partner with biotech and pharma companies to create specialized neuronal models for disease and screening applications. In 2022, BrainXell Therapeutics was launched to advance novel cell therap...
BrainXell, founded in 2015 by stem cell neuroscience pioneer Dr. Su Chun Zhang, develops high purity human neurons from iPSCs to support drug discovery and neurological research. Using proprietary directed differentiation technology, we partner with biotech and pharma companies to create specialized neuronal models for disease and screening applications. In 2022, BrainXell Therapeutics was launched to advance novel cell therapies, with programs in Parkinson’s disease and spinal cord injury aimed at transforming care for patients with neurological disorders.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
455 Science Drive Ste 150 Madison, WI, 53711
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/brainxell-showcases-pioneering-ipsc-research-and-promising-in-vivo-data-for-bxt-110-for-parkinsons-disease-at-the-2025-society-for-neuroscience-annual-meeting-302616241.html

PR NEWSWIRE
15 Nov 2025

https://www.prnewswire.com/news-releases/brainxell-therapeutics-unveils-promising-preclinical-data-demonstrating-efficacy-of-bxt-110-an-autologous-ipsc-derived-neuronal-therapy-in-parkinsons-disease-302602745.html

PR NEWSWIRE
03 Nov 2025

https://www.prnewswire.com/news-releases/brainxell-inc-strengthens-executive-leadership-with-paul-marcus-and-dr-su-chun-zhang-302507554.html

PR NEWSWIRE
17 Jul 2025

https://www.prnewswire.com/news-releases/brainxell-inc-appoints-katherine-vega-stultz-as-chief-executive-officer-and-board-director-302502111.html

PR NEWSWIRE
11 Jul 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty